Sophia Masi, Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Oc.7.830 Program Office, Seattle, WA 98105 Phone: 206-987-2525 |
Angela Monserrate Roig, Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne # Oc.7830, Seattle, WA 98105 Phone: 206-987-2525 |
Helene Mollie Greves Grow, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4245 Roosevelt Way Ne, Seattle, WA 98105 Phone: 206-598-3000 |
Joel S Tieder, Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2000 |
Susanna B. Block, MD, MPH Pediatrics Medicare: Medicare Enrolled Practice Location: 201 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000 |
Troy Alan Johnston, Pediatrics - Pediatric Cardiology Medicare: Accepting Medicare Assignments Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2000 |
Dr. Jill Andrea Cook, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 201 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000 |
Elena M Shephard, Pediatrics - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195 Phone: 206-543-0065 |
Neel Sanjivbhai Bhatt, MD MPH Pediatrics - Pediatric Hematology-Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5000 |
Michael Junxiong Lin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne # Oc.7830, Seattle, WA 98105 Phone: 206-987-2525 |
Danielle Kirkey, Pediatrics Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-520-5000 |
Tania Metai Haag, Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Oc.7.830, Seattle, WA 98105 Phone: 206-987-2525 |
Abigail Ann Laudi, Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne # Oc.7830, Seattle, WA 98105 Phone: 206-987-2525 |
Lauren Carlozzi, Pediatrics Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-205-0005 |
Paula Marsland, Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne # Oc.7830, Seattle, WA 98105 Phone: 206-987-2525 |
Kirsten Eve Mojziszek, Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Oc.7.830, Seattle, WA 98105 Phone: 206-987-2525 |
Margaret Macmillan Vernon, M.D. Pediatrics - Pediatric Cardiology Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Childrens Heart Center Ms G-0035, Seattle, WA 98105 Phone: 206-987-2127 |
Terrence Chun, Pediatrics - Pediatric Cardiology Medicare: Accepting Medicare Assignments Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2000 |
Robin D Ifft, MD Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 |
Laurie S. Fouser, MD Pediatrics - Pediatric Nephrology Medicare: Medicare Enrolled Practice Location: 1101 Madison St Ste 800, Seattle, WA 98104 Phone: 206-215-2700 Fax: 206-215-2702 |
News Archive
For seniors, October is a month in which medications - particularly prescription meds - will likely be on their minds. Not only is October national "Talk About Prescriptions Month," but Oct. 15 marks the start of Medicare's Annual Election Period during which beneficiaries can disenroll from, switch or enroll into a Medicare Advantage or Part D plan.
Pharmaron Holdings Limited, today announced it completed the acquisition of Bridge Laboratories China. Bridge Laboratories China is the leading contract research organization (CRO) in China providing western standard GLP-compliant toxicology services to pharmaceutical and biotech companies from around the world. With this acquisition, Pharmaron becomes the first integrated CRO in China supporting clients with drug discovery and development processes in support of IND filings. This strategic acquisition strengthens Pharmaron's leading position in the fast-growing, highly dynamic pharmaceutical CRO industry.
The University of Illinois at Chicago will lead a $14.6 million, multi-center research project to determine which of two drugs - azithromycin, an antibiotic, or roflumilast, an anti-inflammatory medication - is the most effective at treating chronic obstructive pulmonary disease, which is also known as COPD.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of porphyria including acute intermittent porphyria.
› Verified 2 days ago